Skip to main content
Egyptian Liver Journal

Table 2 Comparison between the three studied groups according to radiological findings and microRNA-130b levels

From: Liver stiffness, hepatorenal index, and microRNA-130b as predictors for chronic kidney disease in patients with non-alcoholic fatty liver disease

 

Group I (n = 20)

Group II (n = 20)

Group III (n = 20)

p*

Liver steatosis

 Normal

0 (0%)

0 (0%)

20 (100%)

 < 0.001

 Mild

10 (50%)

7 (35%)

0 (0%)

 Moderate

10 (50%)

13 (65%)

0 (0%)

HRI

1.5 (1.20–2.28)1,2

1.3 (1.07–1.66)3

1.02 (1.01–1.05)

 < 0.001

ARFI (m/s)

2.97 (2.08–3.68)1,2

2.45 (1.85–3.81)3

1.84 (1.23–2.35)

 < 0.001

miRNA-130b copies/µl

32.1 (24–41.7)1,2

27.01 (22–36)3

24.6 (20.2–29.8)

 < 0.001

  1. HRI, hepatorenal index; ARFI, acoustic radiation force impulse. 1P-value for comparing groups I and II. 2P-value for comparing groups I and III. 3P = value for comparing groups II and III. *Statistically significant at P ≤ 0.05. Group I, patients with NAFLD with CKD; group II, patients with NAFLD without CKD; group III, control
Back to article page